human papillomavirus

NanoVir Reports How Its HPV-Killer WorksNanoVir LLC of Kalamazoo, in partnership with the University of Missouri-St. Louis, has announced the results of a study that characterized the mechanism by which their novel antiviral compounds to prompt cells to selectively destroy human papillomavirus DNA.
Survey: HPV Vaccine Rates Trail Other Teen VaccinesIncreases in vaccination rates for human papillomavirus (HPV) are trailing increases in rates for two other vaccines recommended for teens and preteens, according to data from the Centers for Disease Control and Prevention.